Evidence map›Paper›PMID 32009801›Full record

ArticleOncoTargets and therapy2019

Sodium Selenite Improves The Therapeutic Effect Of BMSCs Via Promoting The Proliferation And Differentiation, Thereby Promoting The Hematopoietic Factors.

Dongmei Yan, Botao Tang, Lixin Yan, Lei Zhang, Meijuan Miao, Xi Chen, Guangyi Sui, Qi Zhang, Daoyuan Liu, Hui Wang

Open access · goldAbstract read
In one paragraph

Article in OncoTargets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Dongmei Yan *Department of Blood Transfusion, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Botao Tang *Department of Cardiology, Heilongjiang Red Cross Hospital, Harbin, People's Republic of China.
Lixin YanDepartment of Laboratory Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Lei ZhangDepartment of Blood Transfusion, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Meijuan MiaoDepartment of Blood Transfusion, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Xi ChenDepartment of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Guangyi SuiEthics Committee, The Tumor Hospital Affiliated to Harbin Medical University, Harbin, People's Republic of China.
Qi ZhangDepartment of Blood Transfusion, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Daoyuan LiuDepartment of Blood Transfusion, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.
Hui WangDepartment of Blood Transfusion, The Second Affiliated Hospital of Harbin Medical University, Harbin, People's Republic of China.ORCID 0000-0002-8349-9526
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSodium selenite (Na

methodsWe evaluated the fate of the MSCs isolated from the bone marrow of mice by studying their differentiation and proliferation after treatment with Na

resultsWhile the mice-derived BMSCs expressed CD44, CD73, CD90, and CD105, they did not express CD45. The morphology of the derived cells was homogeneously elongated. These results showed that the isolated cells are indeed BMSCs. We found that 0.1 μM and 1 μM of Na

conclusionNa

Indexed as

BMSCsclotting timecoagulation factorsdifferentiationproliferationsodium selenite

Identifiers

PMID32009801
PMCPMC6859959
OpenAlexW2993183325

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.